Better Regulatory Environment Necessary

The Ministry of Health in Syria has revealed that the country needs to implement more rigorous drug safety and analysis testing to ensure the quality and efficacy of all medicines entering the country. BMI believes that developing a more comprehensive regulatory system will do much to reduce incidences of drug counterfeiting and therefore will attract multinational pharmaceutical

To read the full article, please choose one of the following options: